JPM vs. ABBV
JPM (JPMorgan Chase & Co.) and ABBV (AbbVie Inc.) are both stocks. JPM operates in Banks - Diversified (Financial Services), while ABBV operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, JPM returned 21.02%/yr vs 19.10%/yr for ABBV. At a 0.30 correlation, their price movements are largely independent.
Performance
JPM vs. ABBV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, JPM achieves a 0.50% return, which is significantly lower than ABBV's 1.30% return. Over the past 10 years, JPM has outperformed ABBV with an annualized return of 21.02%, while ABBV has yielded a comparatively lower 19.10% annualized return.
JPM
- 1D
- 2.31%
- 1M
- 6.82%
- YTD
- 0.50%
- 6M
- 1.66%
- 1Y
- 21.89%
- 3Y*
- 34.22%
- 5Y*
- 17.82%
- 10Y*
- 21.02%
ABBV
- 1D
- 1.32%
- 1M
- 9.22%
- YTD
- 1.30%
- 6M
- 3.65%
- 1Y
- 22.21%
- 3Y*
- 22.39%
- 5Y*
- 18.94%
- 10Y*
- 19.10%
JPM vs. ABBV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
JPM JPMorgan Chase & Co. | 0.50% | 37.27% | 44.29% | 30.63% | -12.64% | 27.75% | -5.53% | 47.26% | -6.62% | 26.76% |
ABBV AbbVie Inc. | 1.30% | 33.08% | 18.86% | -0.23% | 24.01% | 32.43% | 27.72% | 1.47% | -0.96% | 60.07% |
Correlation
The correlation between JPM and ABBV is 0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.10 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.24 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since Jan 2, 2013 | 0.30 |
Over the past year, the correlation between JPM and ABBV has dropped to 0.10 - well below their long-term average of 0.30, suggesting their price drivers have been diverging.
Fundamentals
JPM:
$896.00B
ABBV:
$403.99B
JPM:
$21.08
ABBV:
$2.05
JPM:
15.21
ABBV:
110.96
JPM:
3.14
ABBV:
6.43
JPM:
2.60
ABBV:
14.69
JPM:
$285.09B
ABBV:
$62.82B
JPM:
$173.52B
ABBV:
$46.15B
JPM:
$81.46B
ABBV:
$17.96B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
JPM vs. ABBV — Risk / Return Rank
JPM
ABBV
JPM vs. ABBV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for JPMorgan Chase & Co. (JPM) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| JPM | ABBV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.09 | ||
| Sortino ratioReturn per unit of downside risk | +0.01 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 1.18 | +0.01 |
| Calmar ratioReturn relative to maximum drawdown | 1.42 | 1.29 | +0.13 |
| Martin ratioReturn relative to average drawdown | 3.36 | 2.88 | +0.48 |
Loading charts...
Drawdowns
JPM vs. ABBV - Drawdown Comparison
The maximum JPM drawdown since its inception was -76.16%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for JPM and ABBV.
Loading charts...
Drawdown Indicators
| JPM | ABBV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.16% | -45.09% | -31.07% |
Max Drawdown (1Y)Largest decline over 1 year | -15.47% | -17.32% | +1.85% |
Max Drawdown (3Y)Largest decline over 3 years | -24.42% | -20.74% | -3.68% |
Max Drawdown (5Y)Largest decline over 5 years | -38.77% | -21.92% | -16.85% |
Max Drawdown (10Y)Largest decline over 10 years | -43.63% | -45.09% | +1.46% |
Current DrawdownCurrent decline from peak | -3.66% | -4.60% | +0.94% |
Average DrawdownAverage peak-to-trough decline | -17.62% | -10.71% | -6.91% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.54% | 7.75% | -1.21% |
Volatility
JPM vs. ABBV - Volatility Comparison
JPMorgan Chase & Co. (JPM) and AbbVie Inc. (ABBV) have volatilities of 6.35% and 6.10%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| JPM | ABBV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.35% | 6.10% | +0.25% |
Volatility (6M)Calculated over the trailing 6-month period | 16.67% | 17.85% | -1.18% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.76% | 24.31% | -2.55% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.46% | 22.89% | +1.57% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.39% | 25.73% | +1.66% |
Dividends
JPM vs. ABBV - Dividend Comparison
JPM's dividend yield for the trailing twelve months is around 1.84%, less than ABBV's 2.96% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 2.96% | 2.87% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% |
JPM JPMorgan Chase & Co. | 1.84% | 1.72% | 1.92% | 2.38% | 2.98% | 2.34% | 2.83% | 2.37% | 2.54% | 1.91% | 2.13% | 2.54% |
Financials
JPM vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between JPMorgan Chase & Co. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
JPM vs. ABBV - Profitability Comparison
JPM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, JPMorgan Chase & Co. reported a gross profit of 47.33B and revenue of 73.66B. Therefore, the gross margin over that period was 64.3%.
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a gross profit of 12.53B and revenue of 15.00B. Therefore, the gross margin over that period was 83.5%.
JPM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, JPMorgan Chase & Co. reported an operating income of 20.48B and revenue of 73.66B, resulting in an operating margin of 27.8%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported an operating income of 4.73B and revenue of 15.00B, resulting in an operating margin of 31.6%.
JPM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, JPMorgan Chase & Co. reported a net income of 16.49B and revenue of 73.66B, resulting in a net margin of 22.4%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a net income of 699.00M and revenue of 15.00B, resulting in a net margin of 4.7%.
Frequently Asked Questions
JPM and ABBV have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
JPM has higher volatility (6.35%) compared to ABBV (6.10%). In terms of maximum drawdown, JPM dropped -76.16% vs ABBV's -45.09%.
JPM currently has the higher Sharpe Ratio (1.01 vs 0.92), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for JPM and ABBV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer